Showing results (61-70 of 208) with videos related to
Sort By:
Pageof 21
Cancer Medicine|January 29, 2025
Prognostic Factors for Survival in Adults With Burkitt Lymphoma: A Systematic ReviewAythami de Armas-Castellano, Diego Infante-Ventura, Tasmania Del Pino-Sedeño, et al.Immunotherapy|March 23, 2023
Myelodysplastic syndrome following chimeric antigen receptor T-cell therapy treated with allogenic stem cell transplantationKhalil Saleh, Ahmadreza Arbab, David Ghez, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 3, 2006
Arsenic trioxide in patients with myelodysplastic syndromes: a phase II multicenter studyNorbert Vey, Andre Bosly, Agnes Guerci, et al.Plos One|July 23, 2009
Prognostic significance of new immunohistochemical markers in refractory classical Hodgkin lymphoma: a study of 59 casesDanielle Canioni, Bénédicte Deau-Fischer, Pierre Taupin, et al.European Journal of Radiology|July 27, 2007
Prospective study of bone marrow infiltration in aggressive lymphoma by three independent methods: whole-body MRI, PET/CT and bone marrow biopsyVincent Ribrag, Daniel Vanel, Sophie Leboulleux, et al.Therapeutic Advances in Drug Safety|August 4, 2025
Notch pathway inhibition with crenigacestat (LY3039478) in a phase I first-in-human clinical trial for patients with relapsed or refractory non-Hodgkin lymphoma and B-cell chronic lymphocytic leukemiaJean-Marie Michot, Zsofia Balogh, Jennifer R Brown, et al.European Journal of Cancer (Oxford, England : 1990)|September 18, 2012
Dissociated responses to newer antimyeloma drugs identify a subset of refractory patients with an extremely poor prognosisEtienne Crickx, Sebastian Wittnebel, Florence Pasquier, et al.British Journal of Haematology|October 23, 2024
Conditional survival of younger patients with mantle cell lymphoma: Results from a randomized phase III trial of the European MCL NetworkLinmiao Jiang, Martin Dreyling, Olivier Hermine, et al.Immunotherapy|April 5, 2019
Post-shingles granulomatous dermatosis related to anti-programmed cell death 1Tarek Assi, Alina Danu, Christine Mateus, et al.Cancers|October 27, 2019
Screening a Broad Range of Solid and Haematological Tumour Types for CD70 Expression Using a Uniform IHC Methodology as Potential Patient Stratification MethodTal Flieswasser, Valérie Camara-Clayette, Alina Danu, et al.Pageof 21